0001209191-16-125846.txt : 20160603
0001209191-16-125846.hdr.sgml : 20160603
20160603191618
ACCESSION NUMBER: 0001209191-16-125846
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160601
FILED AS OF DATE: 20160603
DATE AS OF CHANGE: 20160603
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALDER BIOPHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001423824
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11804 NORTH CREEK PARKWAY SOUTH
CITY: BOTHELL
STATE: WA
ZIP: 98011
BUSINESS PHONE: 425-205-2900
MAIL ADDRESS:
STREET 1: 11804 NORTH CREEK PARKWAY SOUTH
CITY: BOTHELL
STATE: WA
ZIP: 98011
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schatzman Randall C
CENTRAL INDEX KEY: 0001604763
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36431
FILM NUMBER: 161697189
MAIL ADDRESS:
STREET 1: 11804 NORTH CREEK PARKWAY SOUTH
CITY: BOTHELL
STATE: WA
ZIP: 98011
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-06-01
0
0001423824
ALDER BIOPHARMACEUTICALS INC
ALDR
0001604763
Schatzman Randall C
11804 NORTH CREEK PARKWAY SOUTH
BOTHELL
WA
98011
1
1
0
0
President and CEO
Common Stock
2016-06-01
4
M
0
10000
1.265
A
124768
D
Common Stock
2016-06-01
4
S
0
8035
29.5064
D
116733
D
Common Stock
2016-06-01
4
S
0
1965
30.2595
D
114768
D
Stock Option (Right to Buy)
1.265
2016-06-01
4
M
0
10000
0.00
D
2017-11-13
Common Stock
10000
38181
D
The exercise of options reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 4, 2015.
Includes 1,821 shares acquired under the Issuer's 2014 Employee Stock Purchase Plan on May 31, 2016.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 4, 2015.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.07 to $30.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 4 to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.07 to $30.42, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 5 to this Form 4.
The option is fully vested.
/s/ Randall C. Schatzman
2016-06-03